But a common concern with GLP-1 medications is the risk of hypoglycemia, or low blood sugar
Erectile function was assessed by the International Index of Erectile Function-Erectile Function domain (IIEF-EF) score
Human and animal studies have shown that PT-141 significantly enhances sexual motivation and performance, but research evaluating its effects on testosterone specifically is limited
Their applications also promote our understanding of the detailed molecular mechanism of vitiligo and are essential for guiding a more precise vitiligo treatment
Despite the disapproval of pharmaceutical companies, doctors and plastic surgeons are experimenting with these treatments to aid patients with gradual weight loss
The MDL is meant to centralize all semaglutide lawsuits involving gastroparesis injuries into one court, under one judge: Each lawsuit contains substantially similar allegations about GLP-1 RAs (specifically, Ozempic, Wegovy, Rybelsus, Trulicity, and/or Mounjaro) and their alleged propensity to cause gastrointestinal injuries. All of these lawsuits share common issues of fact regarding: If defendants knew or should have known that their GLP-1 RA products can cause gastroparesis and other gastrointestinal injuries Whether defendants adequately warned plaintiffs or their prescribing physicians about the alleged dangers of these products Whether defendants made false, misleading, or incomplete representations regarding the safety of these products
